(2R,3S,4R)-2-(Hydroxymethyl)-3,4-dihydro-2H-pyran-3,4-diol, 95.0%, 1g

(2E)-3-(1,3-benzothiazol-2-yl)acrylic acid, 95.0%, 5g

Methyl 2-Hydroxy-3-nitrobenzoate, 97.0%, 100g

Flat flange reaction vessel, cylindrical, graduated, with tempering and vacuum jacket and drain valve, DN 100, 4000 ml, 250 mm, 1 Piece

Extraction attachment, 100 ml, 45/40, 1 Piece

Ethyl-5-amino-2-fluorobenzoate, 95.0%, 1g

5-Bromo-2-isopropoxythiazole, 95.0%, 1g

5-(2,2-DIMETHYLPROPYL)-1H-PYRAZOL-3-AMINE, 95.0%, 5g

2,5,8,11,14,17,20,23-Octaoxahexacosan-26-oic acid, 98%, 10g

5-Chloro-1,3-dimethyl-1H-pyrazole-4-carbonitrile, 95%, 5g

4-Bromo-2,6-dimethylbenzaldehyde, 95.0%, 100g

1-Methylimidazole-2-carboxaldehyde>98.0%(GC)1g

7-Morpholino-6,7,8,9-tetrahydro-5h-benzo[7]annulen-3-amine, 98%, 250mg